person · Reporting owner
SOISTMAN FRANCIS S JR
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MOLINA HEALTHCARE, INC.MOH · Entity 3504 | Director | October 01, 2026 | October 03, 2026 |
| Privia Health Group, Inc.PRVA · Entity 1532 | Director | May 20, 2026 | May 22, 2026 |
| eHealth, Inc.EHTH · Entity 497 | Director | October 01, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MOLINA HEALTHCARE, INC.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,211 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 304 · Balance 1,211 F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares. F3: Represents the closing price of the Issuer's common stock on October 1, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.
F3: Represents the closing price of the Issuer's common stock on October 1, 2026.
Privia Health Group, Inc.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | Direct | 8,463 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 8,463 · Balance 8,463 F1: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
eHealth, Inc.
Report date October 01, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 974,609 |
Ending reported balance
After 2026-10-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-01 · Sale · Disposed 20,306 · Balance 994,915 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026. F2: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6905 to $0.7149, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-10-02 · Sale · Disposed 20,306 · Balance 974,609 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026. F3: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6801 to $0.7023, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.
F2: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6905 to $0.7149, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6801 to $0.7023, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AETNA INC /PA/
Report date November 28, 2018 · Filed November 28, 2018
Section 16 reporting ended · disclosed 2018-11-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 1
1 source rowRow 1 · 2018-11-28 · Disposition to issuer · Disposed 45,590 · Balance 0 F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 0 |
Reported balance
After 2018-11-28 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-11-28 · Disposition to issuer · Disposed 145.3767 · Balance 0 F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F2: Represents the pro rata portion of the stock portion of the Aetna Common Stock Fund held by Reporting Person on October 31, 2018 pursuant to the Aetna Inc. 401(k) Plan. The information is based on information provided by the Plan Trustee as of that date. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $100.50 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-11-28 · Disposition to issuer · Disposed 22,042 · Balance 0 F3: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $103.45 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-11-28 · Disposition to issuer · Disposed 45,246 · Balance 0 F4: Represents SARs granted under the Plan on February 19, 2016. Of this amount, 50% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $125.27 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-11-28 · Disposition to issuer · Disposed 64,528 · Balance 0 F5: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-11-28 · Disposition to issuer · Disposed 19,430 · Balance 0 F6: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-11-28 · Disposition to issuer · Disposed 8,023 · Balance 0 F7: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-11-28 · Disposition to issuer · Disposed 18,871 · Balance 0 F8: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-11-28 · Disposition to issuer · Disposed 14,558.1329 · Balance 0 F9: Represents Deferred Stock Units ("DSUs") previously reported and accrued pursuant to the Plan. These DSUs were canceled for an amount in cash for each DSU equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date. |
Filing footnotes · ownership attribution and instrument terms
F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.
F2: Represents the pro rata portion of the stock portion of the Aetna Common Stock Fund held by Reporting Person on October 31, 2018 pursuant to the Aetna Inc. 401(k) Plan. The information is based on information provided by the Plan Trustee as of that date.
F3: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount").
F4: Represents SARs granted under the Plan on February 19, 2016. Of this amount, 50% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.
F5: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.
F6: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement.
F7: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement.
F8: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement.
F9: Represents Deferred Stock Units ("DSUs") previously reported and accrued pursuant to the Plan. These DSUs were canceled for an amount in cash for each DSU equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2022 Filed Dec 5, 2022 21:11 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-22-000154 · wf-form4_167027465610302.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 578,515 F1 · kind: This represents an award of restricted stock units. Each unit represents a contingent right to receive one share of the company's common stock upon vesting. The restricted stock units vest in eight equal quarterly installments from the vesting commencement date of October 10, 2022, subject to the individual continuing to provide services to the company through the applicable vesting date. Read SEC document |
| November 22, 2022 Filed Nov 25, 2022 19:13 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 80,000 | $3.08 | $246,552.00 |
DisclosureSEC source: 0001333493-22-000152 · wf-form4_166940358324795.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,515 F1 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.01 to $3.14, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the range set forth in this footnote. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 20:31 UTC | eHealth, Inc. EHTH · Entity 497 | Tax withholdingCommon Stock | 245 | $2.73 | $668.85 |
DisclosureSEC source: 0001333493-22-000138 · wf-form4_166759384465218.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,515 F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation. Read SEC document |
| October 10, 2022 Filed Oct 12, 2022 20:07 UTC | eHealth, Inc. EHTH · Entity 497 | Tax withholdingCommon Stock | 11,757 | $3.15 | $37,034.55 |
DisclosureSEC source: 0001333493-22-000136 · wf-form4_166560525414775.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,760 F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 20:12 UTC | eHealth, Inc. EHTH · Entity 497 | Tax withholdingCommon Stock | 4,703 | $4.88 | $22,950.64 |
DisclosureSEC source: 0001333493-22-000127 · wf-form4_166422316065366.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,517 F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:12 UTC | eHealth, Inc. EHTH · Entity 497 | Tax withholdingCommon Stock | 245 | $7.40 | $1,813.00 |
DisclosureSEC source: 0001333493-22-000097 · wf-form4_165964389285311.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,220 F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation. Read SEC document |
| July 10, 2022 Filed Jul 12, 2022 20:23 UTC | eHealth, Inc. EHTH · Entity 497 | Tax withholdingCommon Stock | 11,757 | $8.71 | $102,403.47 |
DisclosureSEC source: 0001333493-22-000090 · wf-form4_165765737379742.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,465 F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation. Read SEC document |
| May 02, 2022 Filed May 4, 2022 23:30 UTC | eHealth, Inc. EHTH · Entity 497 | Tax withholdingCommon Stock | 245 | $8.45 | $2,070.25 |
DisclosureSEC source: 0001333493-22-000059 · wf-form4_165170694050412.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,222 F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation. Read SEC document |
| April 01, 2022 Filed Apr 1, 2022 22:41 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-22-000045 · wf-form4_164885285155530.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,467 F1 · kind: This represents an award of restricted stock units. Each unit represents a contingent right to receive one share of the company's common stock upon vesting. The restricted stock units vest as to 12.5% of the shares at the end of each three-month period after the vesting commencement date of April 10, 2022, such that the Stock Unit shall be 100% vested on the second anniversary of the vesting commencement date, subject the individual continuing to provide services to the company through the applicable vesting date. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 23:14 UTC | eHealth, Inc. EHTH · Entity 497 | Tax withholdingCommon Stock | 287 | $20.55 | $5,897.85 |
DisclosureSEC source: 0001333493-22-000007 · wf-form4_164401642839369.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,467 F1 · kind: Represents the withholding of shares to satisfy tax withholding obligation. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:41 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 5,500 | $29.19 | $160,544.45 |
DisclosureSEC source: 0001333493-21-000177 · wf-form4_163701249048039.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,754 Read SEC document |
| November 02, 2021 Filed Nov 5, 2021 00:07 UTC | eHealth, Inc. EHTH · Entity 497 | GrantPerformance Stock Unit · Derivative | 70,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001333493-21-000162 · wf-form4_163607082840071.xml · derivative · entry 4 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2025-11-02 F4 · derivative.exercise_date: The performance-based restricted stock units will be eligible to vest during a four-year performance period following the award's grant date based on the company's stock price trading at certain pre-determined price thresholds. Once a price threshold is achieved, the portion of the award related to that threshold will vest on the earlier of the first anniversary of the date that the price threshold was met or the fourth anniversary of the date of grant, subject to the individual continuing to provide services to the company through the applicable vesting date. Read SEC document |
| November 02, 2021 Filed Nov 5, 2021 00:07 UTC | eHealth, Inc. EHTH · Entity 497 | Tax withholdingCommon Stock | 246 | $45.70 | $11,242.20 |
DisclosureSEC source: 0001333493-21-000162 · wf-form4_163607082840071.xml · nonDerivative · entry 3 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,254 F3 · kind: Represents the withholding of shares to satisfy tax withholding obligation. Read SEC document |
| November 02, 2021 Filed Nov 5, 2021 00:07 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-21-000162 · wf-form4_163607082840071.xml · nonDerivative · entry 2 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,500 F2 · kind: This represents an award of restricted stock units. Each unit represents a contingent right to receive one share of the company's common stock upon vesting. The restricted stock units vest as to 25% of the shares one year after the the vesting commencement date of September 22, 2021, and the remainder of the shares subject to this award will vest in equal quarterly installments thereafter, subject to the individual continuing to provide services to the company through the applicable vesting date. Read SEC document |
| November 02, 2021 Filed Nov 5, 2021 00:07 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-21-000162 · wf-form4_163607082840071.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · kind: This represents an award of restricted stock units. Each unit represents a contingent right to receive one share of the company's common stock upon vesting. 1/16 of the shares subject to this award vested on the date of grant of November 2, 2021, and the remainder of the shares subject to this award will vest in fifteen equal quarterly installments thereafter, subject to the individual continuing to provide services to the company through the applicable vesting date. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerDeferred Stock Units · Derivative | 14,558.1329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000166 · edgar.xml · derivative · entry 9 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,558.1329 shares Expires not disclosed F9 · derivative.exercise_price: Represents Deferred Stock Units ("DSUs") previously reported and accrued pursuant to the Plan. These DSUs were canceled for an amount in cash for each DSU equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date. F9 · price: Represents Deferred Stock Units ("DSUs") previously reported and accrued pursuant to the Plan. These DSUs were canceled for an amount in cash for each DSU equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date. F9 · derivative.exercise_date: Represents Deferred Stock Units ("DSUs") previously reported and accrued pursuant to the Plan. These DSUs were canceled for an amount in cash for each DSU equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date. F9 · derivative.expiration_date: Represents Deferred Stock Units ("DSUs") previously reported and accrued pursuant to the Plan. These DSUs were canceled for an amount in cash for each DSU equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerRestricted Stock Units · Derivative | 18,871 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000166 · edgar.xml · derivative · entry 8 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,871 shares Expires not disclosed F8 · derivative.exercise_price: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. F8 · price: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. F8 · derivative.exercise_date: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. F8 · derivative.expiration_date: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerPerformance Stock Units · Derivative | 8,023 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000166 · edgar.xml · derivative · entry 7 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,023 shares Expires not disclosed F7 · derivative.exercise_price: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. F7 · price: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. F7 · derivative.exercise_date: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. F7 · derivative.expiration_date: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerPerformance Stock Units · Derivative | 19,430 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000166 · edgar.xml · derivative · entry 6 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,430 shares Expires not disclosed F6 · derivative.exercise_price: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. F6 · price: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. F6 · derivative.exercise_date: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. F6 · derivative.expiration_date: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerStock Appreciation Rights · Derivative | 64,528 | Not disclosed Strike: $125.27 | Not disclosed |
DisclosureSEC source: 0001122304-18-000166 · edgar.xml · derivative · entry 5 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,528 shares Expires not disclosed F5 · price: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F5 · derivative.exercise_date: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F5 · derivative.expiration_date: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerStock Appreciation Rights · Derivative | 45,246 | Not disclosed Strike: $103.45 | Not disclosed |
DisclosureSEC source: 0001122304-18-000166 · edgar.xml · derivative · entry 4 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,246 shares Expires not disclosed F4 · price: Represents SARs granted under the Plan on February 19, 2016. Of this amount, 50% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F4 · derivative.exercise_date: Represents SARs granted under the Plan on February 19, 2016. Of this amount, 50% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. F4 · derivative.expiration_date: Represents SARs granted under the Plan on February 19, 2016. Of this amount, 50% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerStock Appreciation Rights · Derivative | 22,042 | Not disclosed Strike: $100.50 | Not disclosed |
DisclosureSEC source: 0001122304-18-000166 · edgar.xml · derivative · entry 3 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,042 shares Expires not disclosed F3 · price: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). F3 · derivative.exercise_date: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). F3 · derivative.expiration_date: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerCommon Stock | 145.3767 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000166 · edgar.xml · nonDerivative · entry 2 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 F1 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F2 · ownership.nature: Represents the pro rata portion of the stock portion of the Aetna Common Stock Fund held by Reporting Person on October 31, 2018 pursuant to the Aetna Inc. 401(k) Plan. The information is based on information provided by the Plan Trustee as of that date. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:25 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerCommon Stock | 45,590 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000166 · edgar.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:13 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantRestricted Stock Units · Derivative | 18,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-18-000030 · edgar.xml · derivative · entry 5 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,871 Underlying: Common Stock · 18,871 shares Expires not disclosed F6 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a right to receive one share of Aetna Inc. Common Stock net of taxes. F7 · derivative.exercise_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018. F7 · derivative.expiration_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:13 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionPerformance Stock Units · Derivative | 8,956 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-18-000030 · edgar.xml · derivative · entry 4 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,956 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. F5 · derivative.exercise_date: PSUs granted under the Plan. F5 · derivative.expiration_date: PSUs granted under the Plan. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:13 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 5,195 | $177.53 | $922,268.35 |
DisclosureSEC source: 0001122304-18-000030 · edgar.xml · nonDerivative · entry 2 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,590 F3 · shares: Represents tax withholding on vesting of previously reported PSUs. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:13 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 10,748 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000030 · edgar.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of previously reported Performance Stock Units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan"). F2 · price: Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 16:21 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantPerformance Stock Units · Derivative | 8,956 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-17-000134 · edgar.xml · derivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,956 Underlying: Common Stock · 8,956 shares Expires not disclosed F1 · derivative.exercise_price: Performance Stock Units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan. Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net taxes, depending on performance against the specified Company performance target. F2 · derivative.exercise_date: PSUs originally granted on March 2, 2015. Units vest based on both service through March 2, 2018 and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period. Units will fully vest in accordance with the Plan if executive remains employed by the Company through March 2, 2018. F2 · derivative.expiration_date: PSUs originally granted on March 2, 2015. Units vest based on both service through March 2, 2018 and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period. Units will fully vest in accordance with the Plan if executive remains employed by the Company through March 2, 2018. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 16:33 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionRestricted Stock Units · Derivative | 9,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-17-000128 · edgar.xml · derivative · entry 4 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,126 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Aetna Inc. Common Stock net of taxes. F5 · derivative.exercise_date: RSUs granted under the Plan. F5 · derivative.expiration_date: RSUs granted under the Plan. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 16:33 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 4,646 | $181.57 | $843,574.22 |
DisclosureSEC source: 0001122304-17-000128 · edgar.xml · nonDerivative · entry 2 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,037 F3 · shares: Represents tax withholding on vesting of previously reported RSUs. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 16:33 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 9,126 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-17-000128 · edgar.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of previously reported Restricted Stock Units ("RSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan"). F2 · price: Each RSU represents a right to receive one share of Aetna Inc. Common Stock net of taxes. Read SEC document |
| September 18, 2017 Filed Sep 20, 2017 16:39 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionStock Appreciation Right · Derivative | 22,623 | $103.45 Strike: $103.45 | $2,340,349.35 |
DisclosureSEC source: 0001122304-17-000098 · edgar.xml · derivative · entry 6 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,246 Underlying: Common Stock · 22,623 shares Expires 2026-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2017 Filed Sep 20, 2017 16:39 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionStock Appreciation Right · Derivative | 44,084 | $100.50 Strike: $100.50 | $4,430,442.00 |
DisclosureSEC source: 0001122304-17-000098 · edgar.xml · derivative · entry 5 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,042 Underlying: Common Stock · 44,084 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2017 Filed Sep 20, 2017 16:39 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 54,604 | $161.00 | $8,791,244.00 |
DisclosureSEC source: 0001122304-17-000098 · edgar.xml · nonDerivative · entry 3 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,557 F1 · shares: Stock Appreciation Right is net settled; amount represents withholding of shares by the Company to pay exercise price and taxes. Read SEC document |
| September 18, 2017 Filed Sep 20, 2017 16:39 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 22,623 | $103.45 | $2,340,349.35 |
DisclosureSEC source: 0001122304-17-000098 · edgar.xml · nonDerivative · entry 2 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2017 Filed Sep 20, 2017 16:39 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 44,084 | $100.50 | $4,430,442.00 |
DisclosureSEC source: 0001122304-17-000098 · edgar.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 16:09 UTC | AETNA INC /PA/ AET · Entity 107289 | SaleCommon Stock | 6,607 | $131.98 | $872,020.27 |
DisclosureSEC source: 0001122304-17-000029 · edgar.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,454 F1 · price: The price reported is average weighted share price. These shares were sold in multiple transactions at prices ranging from $131.9831 to $131.9870, inclusive. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 17:47 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionStock Appreciation Rights · Derivative | 54,833 | $72.26 Strike: $72.26 | $3,962,232.58 |
DisclosureSEC source: 0001122304-17-000027 · edgar.xml · derivative · entry 6 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,833 shares Expires 2024-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 17:47 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 41,619 | $131.30 | $5,464,574.70 |
DisclosureSEC source: 0001122304-17-000027 · edgar.xml · nonDerivative · entry 2 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,061 F1 · shares: Stock Appreciation Right is net settled; amount represents withholding of shares by the Company to pay exercise price and taxes. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 17:47 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 54,833 | $72.60 | $3,980,875.80 |
DisclosureSEC source: 0001122304-17-000027 · edgar.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 17:47 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionDeferred Stock Unit Account · Derivative | 14,265.24 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001122304-17-000027 · edgar.xml · derivative · entry 5 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,265.24 Underlying: Common Stock · 14,265.24 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Represents vesting of previously reported Performance Stock Units granted under the 2010 Stock Incentive Plan (the "Plan"). Upon vesting the Reporting Person elected to defer units to a stock unit account. F4 · derivative.exercise_date: Performance Stock Units granted under the Plan. F4 · derivative.expiration_date: Performance Stock Units granted under the Plan. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 17:47 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionPerformance Stock Units · Derivative | 7,474 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001122304-17-000027 · edgar.xml · derivative · entry 4 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,474 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Performance Stock Unit represents a right to recieve up to two shares of Aetna Inc. Common Stock. F4 · derivative.exercise_date: Performance Stock Units granted under the Plan. F4 · derivative.expiration_date: Performance Stock Units granted under the Plan. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 16:36 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantStock Appreciation Rights · Derivative | 64,528 | $0.00 Strike: $125.27 | $0.00 |
DisclosureSEC source: 0001231553-17-000008 · edgar.xml · derivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,528 Underlying: Common Stock · 64,528 shares Expires 2027-02-17 F1 · derivative.exercise_date: Stock Appreciation Rights granted under the Aetna Inc. 2010 Stock Incentive Plan, exercisable in three annual installments beginning February 17, 2018. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:34 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionRestricted Stock Units · Derivative | 9,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-16-000300 · edgar.xml · derivative · entry 4 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,126 Underlying: Common Stock · 9,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Aetna Inc. Common Stock net of taxes. F5 · derivative.exercise_date: RSUs granted under the Plan. F5 · derivative.expiration_date: RSUs granted under the Plan. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:34 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 4,645 | $128.27 | $595,814.15 |
DisclosureSEC source: 0001122304-16-000300 · edgar.xml · nonDerivative · entry 2 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,847 F3 · shares: Represents tax withholding on vesting of previously reported RSUs. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:34 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 9,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-16-000300 · edgar.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of previously reported Restricted Stock Units ("RSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan"). F2 · price: Each RSU represents a right to receive one share of Aetna Inc. Common Stock net of taxes. Read SEC document |
| December 09, 2016 Filed Mar 10, 2017 16:07 UTC Amendment | AETNA INC /PA/ AET · Entity 107289 | OtherCommon Stock | 192.7535 | $128.91 | $24,847.85 |
DisclosureSEC source: 0001122304-17-000028 · edgar.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 105.5334 F1 · balance_after: Corrected to include inter-fund transfer of 192.7535 shares of Aetna's Common Stock held by reporting person under the Aetna Inc. 401(k) Plan on December 9, 2016 which was inadvertently excluded from the original filing. Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 16:14 UTC | AETNA INC /PA/ AET · Entity 107289 | SaleCommon Stock | 9,150 | $109.78 | $1,004,477.85 |
DisclosureSEC source: 0001122304-16-000293 · edgar.xml · nonDerivative · entry 1 SOISTMAN FRANCIS S JR · CIK 0001233184 · Exec. VP, Government Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,367 F1 · price: The price reported is average weighted share price. These shares were sold in multiple transactions at prices ranging from $109.71 to $110.00, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.